Mindset Pharma Announces Positive Preclinical Results of DMT Compounds Apr 29 • 3 min read Mindset Pharma Inc. announced that certain of Mindset’s Family 4 compounds, a group of patent-pending novel chemical entities that are inspired by DMT & 5-MeO-DMT, are exhibiting positive in vitro screening characteristics.
COMPASS Pathways launches proposed public offering Apr 28 • 5 min read COMPASS Pathways plc yesterday announced the launch of a proposed public offering of 4,000,000 American Depositary Shares (“ADSs”), each representing one ordinary share.
MindMed Begins Trading on Nasdaq Apr 27 • 2 min read MindMed announced the start of trading on The Nasdaq Capital Market (“Nasdaq”).
Silo Wellness Announces Five New Psychedelic Wellness Retreats in Jamaica Apr 26 • 4 min read Silo Wellness Inc. announced a series of psilocybin-assisted wellness retreats beginning in May. Based in Montego Bay.
MindMed To Commence Trading on Nasdaq Apr 23 • 2 min read MindMed announced today that the ccompany’s subordinate voting shares have been approved for listing on The Nasdaq Capital Market (“Nasdaq”).